(4-(2-(1,4-Dioxa-8-azaspiro[4.5]decan-8- yl)ethoxy)-3-chlorophenyl)boronic acid
98%
- Product Code: 89231
CAS:
1704080-55-6
Molecular Weight: | 341.6 g./mol | Molecular Formula: | C₁₅H₂₁BClNO₅ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as Suzuki-Miyaura reactions, where it acts as a boronic acid reagent. Its structure, featuring a boronic acid group, enables it to form stable covalent bonds with aryl or vinyl halides in the presence of a palladium catalyst, facilitating the construction of complex organic molecules. The inclusion of the 1,4-dioxa-8-azaspiro[4.5]decane moiety enhances its solubility and stability, making it suitable for use in various solvent systems. It is often employed in the pharmaceutical industry for the synthesis of drug intermediates or active pharmaceutical ingredients (APIs), especially in the development of compounds with potential therapeutic applications. Additionally, its unique structure may contribute to the design of novel materials or ligands in coordination chemistry.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.500 | 10-20 days | $1,514.84 |
+
-
|
(4-(2-(1,4-Dioxa-8-azaspiro[4.5]decan-8- yl)ethoxy)-3-chlorophenyl)boronic acid
This compound is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as Suzuki-Miyaura reactions, where it acts as a boronic acid reagent. Its structure, featuring a boronic acid group, enables it to form stable covalent bonds with aryl or vinyl halides in the presence of a palladium catalyst, facilitating the construction of complex organic molecules. The inclusion of the 1,4-dioxa-8-azaspiro[4.5]decane moiety enhances its solubility and stability, making it suitable for use in various solvent systems. It is often employed in the pharmaceutical industry for the synthesis of drug intermediates or active pharmaceutical ingredients (APIs), especially in the development of compounds with potential therapeutic applications. Additionally, its unique structure may contribute to the design of novel materials or ligands in coordination chemistry.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :